<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261015071440N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-19</date_registration>
      <primary_sponsor>Self Funding</primary_sponsor>
      <public_title>Effects of High-Intensity Endurance Training on Selected Blood Markers in Amateur Athletes</public_title>
      <acronym></acronym>
      <scientific_title>Effects of High-Intensity Endurance Training on Erythropoietin (EPO), Albumin, and Total Bilirubin Levels in Amateur Athletes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/94135</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Other, Randomization description: After eligibility screening and obtaining written informed consent, the 20 eligible participants were randomly assigned in a 1:1 ratio to either the experimental group (n = 10) or the control group (n = 10). Randomization was performed using Microsoft Excel to generate a computer-based random allocation sequence.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Exercise-Induced Physiological Responses in Healthy Amateur Athletes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  (n = 10): Participants performed high-intensity endurance training for 12 weeks, with sessions lasting 60–75 minutes at 75–90% of maximum heart rate. Intervention 2: Control group: (n = 10): Participants continued their usual daily activities without receiving the prescribed endurance training intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Effects of High-Intensity Endurance Training on Hematological Markers (EPO, Albumin, Total Bilirubin) in Amateur Athletes.   Details: An experimental study investigating the 12-week impact of high-intensity endurance training on serum Erythropoietin (EPO), albumin, and total bilirubin concentrations among 20 male amateur student-athletes (divided into an experimental group and a control group) at the University of the Punjab, Lahore, Pakistan

When:
The data becomes available upon the publication/registration of the study and will remain accessible as part of the permanent research record

To whom:
Available to researchers, scientific reviewers, and the public/scientific community through institutional and publication platforms.

Conditions:
Can be used for academic research, evidence-based sports science insights, systematic reviews, and meta-analyses, provided proper citation of the source study is maintained.

Where to obtain:
Obtainable from the Department of Sports Sciences and Physical Education, University of the Punjab, Lahore, Pakistan, or via the corresponding author (Alamgir Khan, Email: alamgir.sspe@pu.edu.pk).

How to obtain:
Requests for raw data or additional documentation can be made by contacting the corresponding author via email, subject to institutional ethical guidelines and data sharing policies

Comments:
The study protocol received ethical approval from the Departmental Ethical Committee of the Department of Sports Sciences and Physical Education, University of the Punjab, Lahore, Pakistan (Approval Reference: SPS-751)</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Manzoor khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of sports sciences and physical education university of the punjab</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>0332741015</telephone>
        <email>alamgir.sspe@pu.edu.pk</email>
        <affiliation>University of the Punjab</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Manzoor khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of sports sciences and physical education university of the punjab</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>0332741015</telephone>
        <email>alamgir.sspe@pu.edu.pk</email>
        <affiliation>University of the Punjab</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>minimum exercise background of 6–12 months
, no chronic diseases,
no current medication
no  antioxidant supplementation,</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Participants with a history of chronic diseases or medical conditions that could affect their ability to safely .
participate in high-intensity endurance training.2.Participants currently taking medications or using antioxidant supplements that could influence the study outcomes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  (n = 10): Participants performed high-intensity endurance training for 12 weeks, with sessions lasting 60–75 minutes at 75–90% of maximum heart rate.</i_keyword>
      <i_keyword>Control group: (n = 10): Participants continued their usual daily activities without receiving the prescribed endurance training intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in serum erythropoietin (EPO) concentration, serum albumin, and total bilirubin levels from baseline to after 12 weeks of high-intensity endurance training. Timepoint: At baseline (before the intervention) and after 12 weeks of training (24 hours after the final training session). Method of measurement: Venous blood samples were collected after overnight fasting. Serum EPO was measured using the ELISA method, albumin by the bromocresol green (BCG) colorimetric method, and total bilirubin using the Jendrassik–Grof/Diazo method. Measurements were performed before and after the 12-week intervention.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>No secondary outcome variables were specified. Timepoint: No secondary outcome variables were specified. Method of measurement: No secondary outcome variables were specified.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Self Funding</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-06-22</approval_date>
        <contact_name>Ethical Committee, Department of Sports Sciences and Physical Education, University of the Punjab, L</contact_name>
        <contact_address>Quaid-e-Azam Campus Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
